JF
Jean Francois Potie
Capex Maintenance And Process Owner at Arxada
View Jean's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Capex Maintenance And Process Owner
Jul 2022 - Present · 2 years and 5 months
Senior Fixed Asset Accountant
Mar 2016 - Jul 2022 · 6 years and 4 months
SPX Order to Cash
Credit Controller Order To Cash
Apr 2015 - Mar 2016 · 11 months
Company Details
1001-5000 Employees
Arxada is a global science-based specialty chemicals business creating innovative chemistry and solutions. The company aims to solve the world’s toughest preservation challenges by enhancing sustainability with cleaner, greener solutions. Arxada focuses on multiple end-markets primarily in: Human Health & Nutrition, Home & Personal Care, Paints & Coatings and Wood Protection, providing a broad portfolio of differentiated products and solutions, supported by its science and innovation capabilities, in-depth regulatory know-how and track record in manufacturing and process development. The company’s 3,600 employees contribute to the success of its customers, spanning 24 production sites and 14 R&D centers. Arxada is held by Herens HoldCo Ltd.
Year Founded
2019
Social Media
LinkedinFacebookTwitter
Industry
Chemical Manufacturing, Research, general, Research and testing, IT, Internet, R&D, Pest Control Products, Pest Control Services, Industrial Needs, Protective Coatings, Coatings, Surface Technology
HQ Location
Peter Merian-Strasse 80‎‏‏‎ Basel, Basel-Stadt 4052, CH
Keywords
Smart CombineeringMicrobial Control SolutionsSpecialty Chemical ServicesMaterial ProtectioWood ProtectioCropCDMOComposite MaterialsWhite BiotechNutrition and Infrastructure
Discover More About Cleveland Clinic
Contact Details
  • Email AddressJ**@arxada.com
    Reveal Email
  • Phone Number(xxx)xxx-xxxx
    Reveal Phone

Find verified contacts of Jean Francois Potie in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.